MetLife Investment Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,972
| Closed | -$110K | – | 2552 |
|
|
2021
Q3 | $110K | Buy |
2,972
+1,968
| +196% | +$73K | ﹤0.01% | 2403 |
|
|
2021
Q2 | $59.7K | Sell |
1,004
-1,841
| -65% | -$110K | ﹤0.01% | 2422 |
|
|
2021
Q1 | $191K | Buy |
2,845
+2,438
| +599% | +$163K | ﹤0.01% | 2079 |
|
|
2020
Q4 | $24.6K | Sell |
407
-434
| -52% | -$26.3K | ﹤0.01% | 2262 |
|
|
2020
Q3 | $66.5K | Sell |
841
-1,260
| -60% | -$99.6K | ﹤0.01% | 2259 |
|
|
2020
Q2 | $131K | Buy |
2,101
+1,161
| +124% | +$72.5K | ﹤0.01% | 2128 |
|
|
2020
Q1 | $49.8K | Sell |
940
-1,149
| -55% | -$60.9K | ﹤0.01% | 2226 |
|
|
2019
Q4 | $253K | Buy |
2,089
+490
| +31% | +$59.3K | ﹤0.01% | 1847 |
|
|
2019
Q3 | $290K | Sell |
1,599
-743
| -32% | -$135K | ﹤0.01% | 1728 |
|
|
2019
Q2 | $305K | Buy |
2,342
+762
| +48% | +$99.1K | ﹤0.01% | 1777 |
|
|
2019
Q1 | $385K | Hold |
1,580
| – | – | ﹤0.01% | 1612 |
|
|
2018
Q4 | $301K | Hold |
1,580
| – | – | ﹤0.01% | 1678 |
|
|
2018
Q3 | $518K | Hold |
1,580
| – | – | 0.01% | 1519 |
|
|
2018
Q2 | $493K | Buy |
1,580
+180
| +13% | +$56.2K | 0.01% | 1410 |
|
|
2018
Q1 | $341K | Hold |
1,400
| – | – | ﹤0.01% | 1611 |
|
|
2017
Q4 | $423K | Buy |
+1,400
| New | +$423K | ﹤0.01% | 1494 |
|